Picankibart is a human-derived IgG1kappa antibody targeting IL23A. Picankibart specifically binds to the IL23 p19 subunit and exerts an anti-inflammatory effect by blocking the IL23-mediated signaling pathway.
Molecular Weight:
(144.744 kDa)
Purity:
98.00
CAS Number:
[2622900-74-5]
Target:
Interleukin Related
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted